Covid: Govt asks states to prohibit supply of oxygen for industrial use

Union Health Secretary says the demand for oxygen has already reached 60 per cent of total daily production and is expected to rise further

Oxygen
BS Web Team New Delhi
2 min read Last Updated : Apr 18 2021 | 8:52 PM IST
Union Home Secretary Ajay Bhalla on Sunday wrote to Chief Secretaries of all states, asking them to prohibit oxygen supply for industrial use, except the specified exempted industries, amid reports of acute shortages in hospitals.

As India reports massive spikes day after day during the second wave, hospitals and health systems are increasingly coming under pressure and many states are reporting shortages in medical infrastructure, particulary oxygen. 

"Keeping in view the rapid surge in cases especially in high-burden states, empowered group has recommended to prohibit the supply of oxygen for industrial purposes with the exception of nine specified industries from April 22 and the union government has accepted the decision," Bhalla said in his letter to Chief Secretaries.

"I urge you to issue necessary instructions to all the authorities and ensure compliance of the decision. It will help in augmenting supply of medical oxygen and save precious lives," Bhalla said.

Earlier during the day, Chief Minister Arvind Kejriwal said that Delhi is facing an "acute shortage" of oxygen for coronavirus patients and alleged that the quota of the city has been diverted to other states.

"OXYGEN HAS BECOME AN EMERGENCY IN DEL," he tweeted on Sunday evening.

In a seperate letter to the states, Union Health Secretary Rajesh Bhushan said that the requirement for medical oxygen is a critical component in the treatment of infected patients and that the recent surge has led to a manifold hike in demand on oxygen

"Department for Promotion of Industry & Internal Trade (DPIIT) has conveyed that demand for oxygen has already reached about 60 percent of the total daily production, and is expected to rise further," he said.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusCoronavirus TestsCoronavirus Vaccine

Next Story